A fix kombinációk elönyei a hypertoniás betegek kezelésében

Translated title of the contribution: Advantages of fixed combinations in the treatment of hypertensive patients

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In 60-70% of patients with hypertension, a significant decrease in blood pressure can only be achieved by a combination of antihypertensive drugs. International as well as national guidelines emphasise the numerous advantages and the importance of combination treatment. Fixed combinations are particularly advantageous, as their use improves patients' compliance. This paper summarises the available information on the possible combinations of the nine major antihypertensive drug groups distributed in Hungary, and for details the results published on the recently approved and introduced fixed combination of telmisartan and amlodipine.

Original languageHungarian
Pages (from-to)527-533
Number of pages7
JournalLege Artis Medicinae
Volume21
Issue number8-9
Publication statusPublished - Aug 2011

Fingerprint

Antihypertensive Agents
Hungary
Patient Compliance
Guidelines
Blood Pressure
Hypertension
Therapeutics
telmisartan amlodipine combination

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A fix kombinációk elönyei a hypertoniás betegek kezelésében. / Farsang, C.

In: Lege Artis Medicinae, Vol. 21, No. 8-9, 08.2011, p. 527-533.

Research output: Contribution to journalArticle

@article{f6ca9791a503422da65fb808528eaa88,
title = "A fix kombin{\'a}ci{\'o}k el{\"o}nyei a hypertoni{\'a}s betegek kezel{\'e}s{\'e}ben",
abstract = "In 60-70{\%} of patients with hypertension, a significant decrease in blood pressure can only be achieved by a combination of antihypertensive drugs. International as well as national guidelines emphasise the numerous advantages and the importance of combination treatment. Fixed combinations are particularly advantageous, as their use improves patients' compliance. This paper summarises the available information on the possible combinations of the nine major antihypertensive drug groups distributed in Hungary, and for details the results published on the recently approved and introduced fixed combination of telmisartan and amlodipine.",
keywords = "Combination therapy, Fixed combinations, Hypertension, Telmisartan and amlodipine",
author = "C. Farsang",
year = "2011",
month = "8",
language = "Hungarian",
volume = "21",
pages = "527--533",
journal = "Lege Artis Medicinae",
issn = "0866-4811",
publisher = "Literatura Medica Publishing House",
number = "8-9",

}

TY - JOUR

T1 - A fix kombinációk elönyei a hypertoniás betegek kezelésében

AU - Farsang, C.

PY - 2011/8

Y1 - 2011/8

N2 - In 60-70% of patients with hypertension, a significant decrease in blood pressure can only be achieved by a combination of antihypertensive drugs. International as well as national guidelines emphasise the numerous advantages and the importance of combination treatment. Fixed combinations are particularly advantageous, as their use improves patients' compliance. This paper summarises the available information on the possible combinations of the nine major antihypertensive drug groups distributed in Hungary, and for details the results published on the recently approved and introduced fixed combination of telmisartan and amlodipine.

AB - In 60-70% of patients with hypertension, a significant decrease in blood pressure can only be achieved by a combination of antihypertensive drugs. International as well as national guidelines emphasise the numerous advantages and the importance of combination treatment. Fixed combinations are particularly advantageous, as their use improves patients' compliance. This paper summarises the available information on the possible combinations of the nine major antihypertensive drug groups distributed in Hungary, and for details the results published on the recently approved and introduced fixed combination of telmisartan and amlodipine.

KW - Combination therapy

KW - Fixed combinations

KW - Hypertension

KW - Telmisartan and amlodipine

UR - http://www.scopus.com/inward/record.url?scp=80053536160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053536160&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 527

EP - 533

JO - Lege Artis Medicinae

JF - Lege Artis Medicinae

SN - 0866-4811

IS - 8-9

ER -